LH
55
3
JBHT
75
2
SE
61
-7
BLK
52
3
AES
49
-5
NWL
61
5
CA
56
3
EA
44
-2
KO
46
4
MAT
73
2
INTU
60
8
YUM
57
4
HAL
68
6
CTAS
39
5
DOV
59
2
EL
67
11
ITW
45
11
ALL
58
2
EXC
56
2
PM
60
8
LH
55
3
JBHT
75
2
SE
61
-7
BLK
52
3
AES
49
-5
NWL
61
5
CA
56
3
EA
44
-2
KO
46
4
MAT
73
2
INTU
60
8
YUM
57
4
HAL
68
6
CTAS
39
5
DOV
59
2
EL
67
11
ITW
45
11
ALL
58
2
EXC
56
2
PM
60
8
Financhill
Back

Invesco Bloomberg Analyst Rating Improvers ETF Vs. Revolution Medicines, Inc. Industry Stock Comparison

Buy
63

UPGD
Invesco Bloomberg Analyst Rating Improvers ETF

Last Price:
$76.72
Seasonality Move:
5.42%
Buy
64

RVMD
Revolution Medicines, Inc.

Last Price:
$113.93
Seasonality Move:
-1.63%
Buy
63
Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is a Buy

Is Invesco Bloomberg Analyst Rating Improvers ETF a Buy, Sell or Hold?

  • The current Invesco Bloomberg Analyst Rating Improvers ETF [UPGD] share price is $76.19. The Score for UPGD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • UPGD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Revolution Medicines, Inc. (RVMD) is a Buy

Is Revolution Medicines, Inc. a Buy, Sell or Hold?

  • The current Revolution Medicines, Inc. [RVMD] share price is $107.39. The Score for RVMD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • RVMD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UPGD Stock Price Chart

What is Invesco Bloomberg Analyst Rating Improvers ETF's stock price today?

  • The Invesco Bloomberg Analyst Rating Improvers ETF share price today is $76.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPGD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RVMD Stock Price Chart

What is Revolution Medicines, Inc.'s stock price today?

  • The Revolution Medicines, Inc. share price today is $107.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.

UPGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 19.1 Buy
Relative Strength Index (14 RSI): 59.37 Buy
Chaikin Money Flow: 746 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.59 - 75.93) Buy
Bollinger Bands (100): (73.37 - 75.51) Buy

RVMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.48 Buy
Relative Strength Index (14 RSI): 88.38 Buy
Chaikin Money Flow: 5950544 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.87 - 88.29) Buy
Bollinger Bands (100): (42.5 - 75.96) Buy

UPGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.03 Buy
20-day SMA: 75.39 Buy
50-day SMA: 74.31 Buy
200-day SMA: 72.22 Buy
8-day EMA: 72.42 Buy
20-day EMA: 54.75 Buy
50-day EMA: 30.51 Buy
200-day EMA: 9.17 Buy

RVMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.89 Buy
20-day SMA: 81.66 Buy
50-day SMA: 73.85 Buy
200-day SMA: 48.59 Buy
8-day EMA: 89.67 Buy
20-day EMA: 83.17 Buy
50-day EMA: 74.2 Buy
200-day EMA: 54.94 Buy

Invesco Bloomberg Analyst Rating Improvers ETF Earnings Growth & UPGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.59 per share.

Invesco Bloomberg Analyst Rating Improvers ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revolution Medicines, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):